Dissecting gene dysregulation at the maternal-fetal interface in preeclampsia
剖析先兆子痫母胎界面的基因失调
基本信息
- 批准号:10428569
- 负责人:
- 金额:$ 35.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAngiogenic FactorBasement membraneBiological MarkersBloodBlood VesselsCell Adhesion MoleculesCell Culture TechniquesCell surfaceCellsChorionic villiClinicalCorticotropin-Releasing HormoneDataDeciduaDefectEnvironmentExtracellular SpaceFamily memberFetal Growth RetardationFetusFundingGene ExpressionGene Expression ProfilingGenesGenetic TranscriptionHomeobox GenesHormonesHumanImmuneImpairmentInhibin AInvestigationKISS1 geneLasersLearningLigandsLinkMaternal-Fetal ExchangeMesenchymalMicroarray AnalysisMicrodissectionModelingMolecularMolecular AbnormalityMorphologyMothersMultipotent Stem CellsMyometrialNamesNatureNeuropilin-1OrganPI3K/AKTPathologicPathologyPathway interactionsPatientsPatternPhenocopyPhenotypePlacentaPlayPopulationPre-EclampsiaPredictive ValuePregnancyPregnancy ComplicationsProductionQuantitative Reverse Transcriptase PCRRoleSignal TransductionSiteSomatotropinSpiral Artery of the EndometriumSurfaceSyncytiotrophoblastSyndromeTestingTranslatingUp-RegulationUterusVascular Endothelial Growth FactorsVillusWomanWorkarterioleautocrinebasecadherin 5cadherin-6circulating biomarkerscytotrophoblastdiagnostic valuedifferential expressionexperimental studygene productgenetic signatureimprovedin vivoinsightinterestinterstitialnotch proteinnovelpublic health relevancetheoriestherapeutic targettissue inhibitor of metalloproteinase 4transcriptometranscriptomicstranslational potentialtrophoblasttrophoblast stem cellvascular factor
项目摘要
DESCRIPTION (provided by applicant): We are testing the hypothesis that global gene expression profiling of the major trophoblast (TB) subpopulations of placentas from preeclampsia (PE) patients will lead to the identification of novel molecules that play important roles in this syndrome. The impetus for this strategy is the finding that PE is consistently associated with certain placental pathologies. The interstitial component of cytotrophoblast (CTB) invasion is frequently restricted to the superficial decidua. Likewise, endovascular invasion is constrained in terms of the number of spiral arterioles that are involved and the extent to which they are modified. Syncytiotrophoblasts (STBs) from placentas of affected patients also have overt changes such as syncytial knots. These alterations are accompanied by molecular changes, many of which have been identified by profiling, in PE, the expression of molecules that normally play important roles in terms of TB functions. However, we have begun to apply unbiased approaches to gain a more comprehensive understanding of changes in TB gene expression that occur in PE. This approach acknowledges our limited understanding of the placental component of this syndrome. Recently, we used a transcriptomics approach to profile CTB gene expression in various severe forms of PE (sPE). Specifically, CTBs that were isolated from the placentas of sPE patients and control women were cultured for 48 h to allow differentiation/invasion. Microarray analyses revealed sPE-associated upregulation of a suite of CTB genes that, by the end of the culture period, returned to control levels. They included factors previously associated with PE and many novel molecules, including the angiogenic regulator, SEMA3B. We went on to show that elevating levels of this neuropilin-1 and -2 ligand phenocopied many of the effects of PE on CTBs by mechanisms that include downregulating VEGF signaling through the PI3K/AKT and GSK3α/β pathway. The same changes were observed in sPE CTBs. Our data support the theory that, in PE, the in vivo environment impairs CTB differentiation/invasion, the differentially expressed molecules contribute to the mechanisms, and that the clinical signs are determined by patient-specific factors. Having identified a genetic signature for invasive CTBs in sPE, we now propose an unbiased analysis of the three other affected TB populations, STBs, syncytial knots and endovascular CTBs. Specifically; we will use laser microdissection to isolate these cells from PE, sPE and control placentas and a global transcriptional profiling approach to identify the dysregulated genes (Aim 1). We will employ our new cell culture model, human TB progenitor cells, to determine the functional significance of the observed changes (Aim 2). We think that these experiments will yield new information about the molecular bases of placental defects in PE. The findings could also have significant translational potential, e.g., a subset of the dysregulated molecules could be circulating biomarkers and/or therapeutic targets for improving placental function, which our data suggest is possible.
描述(由申请人提供):我们正在测试一个假设,即来自子痫前期(PE)患者胎盘主要滋养细胞(TB)亚群的全球基因表达谱分析将导致鉴定在该综合征中起重要作用的新分子。这种策略的推动力是发现PE始终与某些胎盘病理相关。细胞滋养细胞(CTB)侵袭的间质成分通常局限于浅表蜕膜。同样,受影响的螺旋小动脉的数量和它们被改变的程度限制了血管内侵犯。来自患者胎盘的合胞滋养细胞(STBs)也有明显的变化,如合胞结。这些改变伴随着分子变化,其中许多已通过PE中通常在结核病功能方面发挥重要作用的分子表达谱确定。然而,我们已经开始采用无偏见的方法来更全面地了解PE中TB基因表达的变化。这种方法承认我们对该综合征的胎盘成分的了解有限。最近,我们使用转录组学方法来分析各种严重PE (sPE)中的CTB基因表达。具体来说,从sPE患者和对照组女性的胎盘中分离的CTBs培养48小时,使其能够分化/侵袭。微阵列分析显示,spe相关的一组CTB基因上调,在培养期结束时,恢复到控制水平。它们包括先前与PE相关的因子和许多新分子,包括血管生成调节剂SEMA3B。我们进一步表明,这种神经匹林-1和-2配体水平的升高,通过PI3K/AKT和GSK3α/β途径下调VEGF信号通路的机制,表型上反映了PE对CTBs的许多影响。在sPE CTBs中也观察到相同的变化。我们的数据支持这样的理论:在PE中,体内环境损害CTB的分化/侵袭,差异表达的分子参与了机制,临床症状是由患者特异性因素决定的。在确定了sPE中侵袭性CTBs的遗传特征后,我们现在提出对其他三种受影响的TB人群,STBs,合胞结和血管内CTBs进行无偏倚分析。明确;我们将使用激光显微解剖从PE、sPE和对照胎盘中分离这些细胞,并使用全局转录谱方法来鉴定失调基因(目的1)。我们将采用我们的新细胞培养模型,人类结核祖细胞,来确定观察到的变化的功能意义(目的2)。我们认为这些实验将为PE胎盘缺陷的分子基础提供新的信息。这些发现也可能具有重要的转化潜力,例如,失调分子的一个子集可能是循环生物标志物和/或改善胎盘功能的治疗靶点,我们的数据表明这是可能的。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Preeclampsia and Inflammatory Preterm Labor Alter the Human Placental Hematopoietic Niche.
先兆子痫和炎症性早产改变了人类胎盘造血生态位。
- DOI:10.1177/1933719116632926
- 发表时间:2016
- 期刊:
- 影响因子:0
- 作者:Ponder,KathrynL;Bárcena,Alicia;Bos,FrankL;Gormley,Matthew;Zhou,Yan;Ona,Katherine;Kapidzic,Mirhan;Zovein,AnnC;Fisher,SusanJ
- 通讯作者:Fisher,SusanJ
Stromal Cell-Derived Factor 2: A Novel Protein that Interferes in Endoplasmic Reticulum Stress Pathway in Human Placental Cells.
- DOI:10.1095/biolreprod.115.138164
- 发表时间:2016-08
- 期刊:
- 影响因子:3.6
- 作者:Lorenzon-Ojea AR;Guzzo CR;Kapidzic M;Fisher SJ;Bevilacqua E
- 通讯作者:Bevilacqua E
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUSAN J. FISHER其他文献
SUSAN J. FISHER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUSAN J. FISHER', 18)}}的其他基金
Mass Spectrometry-based Global Molecular Approaches and Computational Tools to Determine Phenotypic and Environmental Signatures of Endometriosis
基于质谱的全局分子方法和计算工具来确定子宫内膜异位症的表型和环境特征
- 批准号:
10699969 - 财政年份:2021
- 资助金额:
$ 35.61万 - 项目类别:
Mass Spectrometry-based Global Molecular Approaches and Computational Tools to Determine Phenotypic and Environmental Signatures of Endometriosis
基于质谱的全局分子方法和计算工具来确定子宫内膜异位症的表型和环境特征
- 批准号:
10308249 - 财政年份:2021
- 资助金额:
$ 35.61万 - 项目类别:
Mass Spectrometry-based Global Molecular Approaches and Computational Tools to Determine Phenotypic and Environmental Signatures of Endometriosis
基于质谱的全局分子方法和计算工具来确定子宫内膜异位症的表型和环境特征
- 批准号:
10458759 - 财政年份:2021
- 资助金额:
$ 35.61万 - 项目类别:
Dissecting gene dysregulation at the maternal-fetal interface in preeclampsia
剖析先兆子痫母胎界面的基因失调
- 批准号:
10329277 - 财政年份:2018
- 资助金额:
$ 35.61万 - 项目类别:
Dissecting gene dysregulation at the maternal-fetal interface in preeclampsia
剖析先兆子痫母胎界面的基因失调
- 批准号:
10178054 - 财政年份:2018
- 资助金额:
$ 35.61万 - 项目类别:
Dissecting gene dysregulation at the maternal-fetal interface in preeclampsia
剖析先兆子痫母胎界面的基因失调
- 批准号:
9750750 - 财政年份:2018
- 资助金额:
$ 35.61万 - 项目类别:
THC effects on human implantation: role of trophoblast CB1
THC 对人体着床的影响:滋养层 CB1 的作用
- 批准号:
9224975 - 财政年份:2017
- 资助金额:
$ 35.61万 - 项目类别:
Dissecting gene dysregulation at the maternal-fetal interface in preeclampsia
剖析先兆子痫母胎界面的基因失调
- 批准号:
8630145 - 财政年份:2013
- 资助金额:
$ 35.61万 - 项目类别:
Dissecting gene dysregulation at the maternal-fetal interface in preeclampsia
剖析先兆子痫母胎界面的基因失调
- 批准号:
8739303 - 财政年份:2013
- 资助金额:
$ 35.61万 - 项目类别:
Dissecting gene dysregulation at the maternal-fetal interface in preeclampsia
剖析先兆子痫母胎界面的基因失调
- 批准号:
9094682 - 财政年份:2013
- 资助金额:
$ 35.61万 - 项目类别:
相似国自然基金
负载类血管生成因子3的可注射水凝胶局部控释体系构建及其对糖尿病下肢缺血病变的治疗作用
- 批准号:51973125
- 批准年份:2019
- 资助金额:58.0 万元
- 项目类别:面上项目
血管生成因子AGGF1在机体抗DNA病毒天然免疫中的作用及调控机制
- 批准号:81801556
- 批准年份:2018
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
IL-21致KC分泌促血管生成因子调控银屑病微血管异常增生的机制研究
- 批准号:81703130
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
类血管生成因子4对2型糖尿病肾小球病变的作用和调控机制
- 批准号:81670765
- 批准年份:2016
- 资助金额:69.0 万元
- 项目类别:面上项目
血管生成因子AGGF1调节高血压心肌重构的作用及机制研究
- 批准号:81500320
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
ERRγ对胎盘血管生成因子的调节及其在子痫前期发病中的作用机制研究
- 批准号:81401209
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
血管生成因子及受体在颅咽管瘤放疗敏感性中的作用及机制研究
- 批准号:81470113
- 批准年份:2014
- 资助金额:30.0 万元
- 项目类别:面上项目
CSE和CBS对胎盘血管生成因子和抗血管生成因子的调节作用及其与子痫前期发生和发展的关系
- 批准号:81370734
- 批准年份:2013
- 资助金额:70.0 万元
- 项目类别:面上项目
银屑病皮损真皮乳头层血管增生与促血管生成因子及细胞外基质的生物力学研究
- 批准号:81101210
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
卵巢癌休眠及复发过程中血管生成因子的表观遗传调控
- 批准号:30973185
- 批准年份:2009
- 资助金额:33.0 万元
- 项目类别:面上项目
相似海外基金
How angiogenic factor induces immunosuppressive cells to tumor microenvironment
血管生成因子如何诱导免疫抑制细胞进入肿瘤微环境
- 批准号:
22KJ0818 - 财政年份:2023
- 资助金额:
$ 35.61万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
- 批准号:
10711027 - 财政年份:2021
- 资助金额:
$ 35.61万 - 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
- 批准号:
10297199 - 财政年份:2021
- 资助金额:
$ 35.61万 - 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
- 批准号:
10625314 - 财政年份:2021
- 资助金额:
$ 35.61万 - 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
- 批准号:
10405070 - 财政年份:2021
- 资助金额:
$ 35.61万 - 项目类别:
Physiological role of anti-angiogenic factor thrombospondin in the regulation of endometrial function during early pregnancy in cattle
抗血管生成因子血小板反应蛋白在牛妊娠早期子宫内膜功能调节中的生理作用
- 批准号:
20K06385 - 财政年份:2020
- 资助金额:
$ 35.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of lymphangiogenic regulatory mechanism of angiogenic factor CCN2 through tumor-associated macrophage
阐明血管生成因子CCN2通过肿瘤相关巨噬细胞的淋巴管生成调节机制
- 批准号:
17K11866 - 财政年份:2017
- 资助金额:
$ 35.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of vascular stabilization mechanism by anti-angiogenic factor vasohibin-1
抗血管生成因子 vasohibin-1 阐明血管稳定机制
- 批准号:
15K20874 - 财政年份:2015
- 资助金额:
$ 35.61万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
angiogenic therapy for cerebral infarction with anti^sense homology derived peptide targeting angiogenic factor
靶向血管生成因子的反义同源肽治疗脑梗死
- 批准号:
15K15523 - 财政年份:2015
- 资助金额:
$ 35.61万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
The development of the anti-angiogenic factor VEGF-A165b quantification methods for cardiovascular disease.
心血管疾病抗血管生成因子 VEGF-A165b 定量方法的开发。
- 批准号:
26860367 - 财政年份:2014
- 资助金额:
$ 35.61万 - 项目类别:
Grant-in-Aid for Young Scientists (B)